Stéphane Terry

5.8k citations

68 papers · 3.6k indexed · h-index 33

Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 11
Pulmonary and Respiratory Medicine top 2%
- Prostate Cancer Treatment and Research 28
- Prostate Cancer Diagnosis and Treatment 13
Oncology top 2%
- Cancer Immunotherapy and Biomarkers 12
- Cancer Cells and Metastasis 9
Urology top 2%
Immunology top 5%
- Immune cells in cancer 8
Rheumatology
- Urologic and reproductive health conditions 9
Biotechnology
- Cancer Research and Treatments 7

Co-authors: Salem Chouaı̈b Francis Vacherot Alexandre de la Taille Himisha Beltran Yves Allory Jean Paul Thiery Muhammad Zaeem Noman Nathalie Nicolaı̈ew
Cited by: Cancer Research Pulmonary and Respiratory Medicine Oncology
Journals: Cancer Research (5 papers)Frontiers in Immunology (4 papers)OncoImmunology (4 papers)
Partner nations: France United States United Arab Emirates

In The Last Decade

Stéphane Terry

65 papers receiving 3.6k citations

Peers

Countries citing papers authored by Stéphane Terry

Since Specialization

Citations

This map shows the geographic impact of Stéphane Terry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane Terry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane Terry more than expected).

Fields of papers citing papers by Stéphane Terry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane Terry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane Terry. The network helps show where Stéphane Terry may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Stéphane Terry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Stéphane Terry Line = papers co-authored together Stéphane Terry links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Designing Organoid Models to Monitor Cancer Progression, Plasticity and Resistance: The Right Set Up for the Right Question Cancers ·Tegan Hargraves,Dinar Aulia Rahma,Kelly DeBrine,Stéphane Terry,Salem Chouaı̈b,Pierre Savagner	2022	2
2	Cancer stem-like cells evade CD8⁺CD103⁺ tumor-resident memory T (T_RM) lymphocytes by initiating an epithelial-to-mesenchymal transition program in a human lung tumor model Journal for ImmunoTherapy of Cancer ·Stéphanie Corgnac,A. Celislami,Gwendoline Gros,Zhen Wei-tao,Stéphane Terry,Salem Chouaı̈b,Marc Deloger,Fathia Mami‐Chouaib	2022	27
3	The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer British Journal of Cancer ·J. F. Chang,Anissa Moktefi,Ariane Jolly,Pierre de la Grange,Denise Gay,Nathalie Nicolaı̈ew,Helen Casey,Pascale Maillé,Pascale Soyeux,Virginie Firlej,Francis Vacherot,Damien Destouches,Mohamed Amiche,Stéphane Terry,Alexandre de la Taille,Arturo Londoño‐Vallejo,Yves Allory,Jean Delbé,Yamina Hamma‐Kourbali	2022	10
4	Dissecting the Role of AXL in Cancer Immune Escape and Resistance to Immune Checkpoint Inhibition Frontiers in Immunology ·Agnete S. T. Engelsen,Maria L. Lotsberg,Raefa Abou Khouzam,Jean Paul Thiery,James B. Lorens,Salem Chouaı̈b,Stéphane Terry	2022	47
5	Tumor hypoxia: an important regulator of tumor progression or a potential modulator of tumor immunogenicity? OncoImmunology ·Goutham Hassan Venkatesh,Raefa Abou Khouzam,Walid El‐Sayed,Price Amerson,Stéphane Terry,Salem Chouaı̈b	2021	18
6	Waterpipe smoke condensate influences epithelial to mesenchymal transition and interferes with the cytotoxic immune response in non-small cell lung cancer cell lines Oncology Reports ·Rania Faouzi Zaarour,Zhou Jiaquan,Goutham Hassan Venkatesh,Raefa Abou Khouzam,Amirtharaj Francis,Price Amerson,In-Cheol Kang,Stéphane Terry,Teodoro López Rodríguez,Omar Kolt,Salem Chouaı̈b	2021	7
7	Decoding cancer’s camouflage: epithelial-mesenchymal plasticity in resistance to immune checkpoint blockade Cancer Drug Resistance ·Maria L. Lotsberg,R. Le Pelley,Jean Paul Thiery,総務省大臣官房企画課,С. Г. Сучков,James B. Lorens,Salem Chouaı̈b,Stéphane Terry,Agnete S. T. Engelsen	2020	10
8	AXL Targeting Overcomes Human Lung Cancer Cell Resistance to NK- and CTL-Mediated Cytotoxicity Cancer Immunology Research ·Stéphane Terry,Eva Ebli,Agnete S. T. Engelsen,Stéphanie Buart,Philippe Dessen,Stéphanie Corgnac,Júlia Andrade da Silva Rosa,Guillaume Meurice,Gro Gausdal,Véronique Baud,邹筱,最上敏樹,Jean Paul Thiery,Fathia Mami‐Chouaib,Salem Chouaı̈b	2019	61
9	Role of Hypoxic Stress in Regulating Tumor Immunogenicity, Resistance and Plasticity International Journal of Molecular Sciences ·Stéphane Terry,Rania Faouzi Zaarour,Goutham Hassan Venkatesh,Amirtharaj Francis,Walid El‐Sayed,Stéphanie Buart,Matteo Pasca,Jérôme Thiery,Salem Chouaı̈b	2018	68
10	Cancer Immunotherapy 2017 (Paris, France). Progress and challenges Bulletin du Cancer ·Kirankumar Shivsharanappa,Stéphane Terry,Stéphanie Corgnac,Agnete S. T. Engelsen	2018	1
11	Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling Cancer Letters ·Roxana Milagritos Reyes González,Ahmad Daher,Damien Destouches,Virginie Firlej,Enis Kostallari,Pascale Maillé,E. Huet,F. Buntinx,Guido Jenster,Alexandre de la Taille,Raghida Abou Merhi,Stéphane Terry,Francis Vacherot	2017	30
12	Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer Cancer ·Stéphane Terry,Nathalie Nicolaı̈ew,Lian Zhen Wang,Helen Casey,Pascale Soyeux,Pascale Maillé,Francis Vacherot,Guillaume Ploussard,Arturo Londoño‐Vallejo,Alexandre de la Taille,Yves Allory	2015	29
13	Cross Modulation between the Androgen Receptor Axis and Protocadherin-PC in Mediating Neuroendocrine Transdifferentiation and Therapeutic Resistance of Prostate Cancer Neoplasia ·Stéphane Terry,Pascale Maillé,Omar Rivasplata,Laurence Kheuang,Pascale Soyeux,Nathalie Nicolaı̈ew,Jocelyn Céraline,Virginie Firlej,Himisha Beltran,Yves Allory,Alexandre de la Taille,Francis Vacherot	2013	43
14	The Risk of Upstaged Disease Increases with Body Mass Index in Low-Risk Prostate Cancer Patients Eligible for Active Surveillance European Urology ·Guillaume Ploussard,Alexandre de la Taille,Volodymyr OPENKO,Xavier Durand,Stéphane Terry,Évanguelos Xylinas,Yves Allory,Francis Vacherot,Claude-Clément Abbou,Laurent Salomon	2011	24
15	Class III β-Tubulin Expression Predicts Prostate Tumor Aggressiveness and Patient Response to Docetaxel-Based Chemotherapy Cancer Research ·Guillaume Ploussard,Stéphane Terry,Pascale Maillé,Yves Allory,Nanor Sirab,Laurence Kheuang,Pascale Soyeux,Nathalie Nicolaı̈ew,Tara Jaiswal,Bernard Paule,Laurent Salomon,Stéphane Culine,Ralph Buttyan,Francis Vacherot,Alexandre de la Taille	2010	121
16	FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data Genome biology ·Andrea Sboner,Lukas Habegger,Dorothee Pflueger,Stéphane Terry,David Ziyou Chen,Joel Rozowsky,Ashutosh Tewari,Naoki Kitabayashi,B.J. Moss,Mark S. Chee,Francesca Demichelis,Mark A. Rubin,Mark Gerstein	2010	110
17	Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing Genome Research ·Dorothee Pflueger,Stéphane Terry,Andrea Sboner,Lukas Habegger,Raquel Esgueva,雅婷刘,Maria A. Svensson,Naoki Kitabayashi,B.J. Moss,Theresa Y. MacDonald,Xuhong Cao,Terrence R. Barrette,Ashutosh Tewari,Mark S. Chee,Arul M. Chinnaiyan,David S. Rickman,Francesca Demichelis,Mark Gerstein,Mark A. Rubin	2010	157
18	Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life Prostate Cancer and Prostatic Diseases ·Guillaume Ploussard,Bernard Paule,Laurent Salomon,Yves Allory,Stéphane Terry,Dimitri Vordos,A. Hoznek,Francis Vacherot,Warren Kemuel M Pan,Stéphane Culine,Alexandre de la Taille	2009	8
19	Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression The Journal of Pathology ·Sandy Azoulay,Stéphane Terry,Shixiang Jing,Nanor Sirab,Efalou Pouwemdéou Jacques,Sixtina Gil Diez de Medina,Stéphane Moutereau,Patrick Maillé,Pascale Soyeux,C.C. Abbou,Laurent Salomon,Francis Vacherot,Alexandre de la Taille,Sylvain Loric,Yves Allory	2008	60
20	Neuroendocrine Differentiation in Prostate Cancer: From Lab to Bedside Urologia Internationalis ·Luca Cindolo,Monica Cantile,Francis Vacherot,Stéphane Terry,Alexandre de la Taille	2007	37

About Stéphane Terry

Stéphane Terry is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Immunology, having authored 68 papers that have together received 3.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (28 papers), Prostate Cancer Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (12 papers), Cancer, Hypoxia, and Metabolism (11 papers), Cancer Cells and Metastasis (9 papers), Urologic and reproductive health conditions (9 papers), Immune cells in cancer (8 papers) and Cancer Research and Treatments (7 papers). The work is most often cited by research in Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (1.4k citations) and Oncology (1.1k citations). Stéphane Terry has collaborated with scholars based in France, United States and United Arab Emirates. Frequent co-authors include Salem Chouaı̈b, Francis Vacherot, Alexandre de la Taille, Himisha Beltran, Yves Allory, Jean Paul Thiery, Muhammad Zaeem Noman, Nathalie Nicolaı̈ew, Bassam Janji and Meriem Hasmim. Their work appears in journals such as Cancer Research, Frontiers in Immunology, OncoImmunology, European Urology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact